IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone

PHASE4

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped There was a delay in recruitment initiation due to COVID-19 and internal logistical challenges. Following this delay, the principal investigator left the study site, and it was determined that the study should be terminated.

Conditions

Interstitial Cystitis
Painful Bladder Syndrome
Bladder Pain Syndrome
Low Dose Naltrexone
Low-dose Naltrexone
Naltrexone

Interventions

DRUG: low-dose naltrexone
DRUG: Placebo oral tablet

Sponsor

Endeavor Health